Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
09 déc. 2024 07h25 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™ Magnetic...
Microwave Ablation Devices Market to Surpass $1 Billion by 2034 Driven by Advances in Cancer Treatment | Transparency Market Research, Inc.
06 déc. 2024 06h55 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc.-, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Microwave ablation (MWA) technology represents a groundbreaking approach to tumor...
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
02 déc. 2024 08h45 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’ latest...
Minimally invasive intervention program set to revolutionize open-heart surgery in Alberta
28 nov. 2024 12h08 HE
|
Calgary Health Foundation
Calgary, Alberta, Canada, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Calgary Health Foundation announces a $3.52M commitment toward the establishment of an innovative heart valve intervention program at...
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
25 nov. 2024 08h21 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced regulatory approval of the...
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
20 nov. 2024 08h18 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
13 nov. 2024 08h00 HE
|
PRISM MarketView
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
06 nov. 2024 08h25 HE
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
27 oct. 2024 08h15 HE
|
HeartFlow Holding, Inc.
— Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease -– FFRCT further...
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
21 oct. 2024 08h41 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...